JP2006514116A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514116A5
JP2006514116A5 JP2005510345A JP2005510345A JP2006514116A5 JP 2006514116 A5 JP2006514116 A5 JP 2006514116A5 JP 2005510345 A JP2005510345 A JP 2005510345A JP 2005510345 A JP2005510345 A JP 2005510345A JP 2006514116 A5 JP2006514116 A5 JP 2006514116A5
Authority
JP
Japan
Prior art keywords
medicament
prevention
patient
item
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005510345A
Other languages
English (en)
Other versions
JP2006514116A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/038175 external-priority patent/WO2004047771A2/en
Publication of JP2006514116A publication Critical patent/JP2006514116A/ja
Publication of JP2006514116A5 publication Critical patent/JP2006514116A5/ja
Pending legal-status Critical Current

Links

Claims (1)

  1. ガンの治療又は予防を必要とする患者のガンを治療又は予防することにおいて使用するための、治療上有効な量の請求項１、２、３、４、５〜２６、２７及び２９のいずれか１項に記載の化合物を含んで成る医薬。
JP2005510345A 2002-11-25 2003-11-25 血管形生、細胞移動、細胞侵入及び細胞増殖を阻害するペプチド、組成物及びそれらの使用 Pending JP2006514116A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42917402P 2002-11-25 2002-11-25
US47553903P 2003-06-02 2003-06-02
PCT/US2003/038175 WO2004047771A2 (en) 2002-11-25 2003-11-25 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof

Publications (2)

Publication Number Publication Date
JP2006514116A JP2006514116A (ja) 2006-04-27
JP2006514116A5 true JP2006514116A5 (ja) 2007-02-15

Family

ID=32397181

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2005512876A Pending JP2006515866A (ja) 2002-11-25 2003-11-25 腫瘍および内皮細胞を標的とするペプチド、その組成物および使用
JP2005510345A Pending JP2006514116A (ja) 2002-11-25 2003-11-25 血管形生、細胞移動、細胞侵入及び細胞増殖を阻害するペプチド、組成物及びそれらの使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2005512876A Pending JP2006515866A (ja) 2002-11-25 2003-11-25 腫瘍および内皮細胞を標的とするペプチド、その組成物および使用

Country Status (14)

Country Link
US (2) US20050020810A1 (ja)
EP (2) EP1594521A4 (ja)
JP (2) JP2006515866A (ja)
KR (2) KR20050097494A (ja)
AU (2) AU2003298726A1 (ja)
BR (2) BR0316523A (ja)
CA (2) CA2507045A1 (ja)
EA (2) EA200500871A1 (ja)
HR (2) HRP20050585A2 (ja)
MX (2) MXPA05005545A (ja)
NO (2) NO20053112L (ja)
NZ (2) NZ540363A (ja)
PL (2) PL377763A1 (ja)
WO (2) WO2004063213A2 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200500871A1 (ru) * 2002-11-25 2006-04-28 Атеньюон, Ллк Пептиды, ингибирующие ангиогенез, миграцию клеток, инвазию клеток и пролиферацию клеток, композиции и их применение
WO2005114194A1 (en) * 2004-05-21 2005-12-01 Mds Inc. Doing Business Through Its Mds Pharma Services Division Method of quantifying the cell-binding properties of a medical device
US20060078535A1 (en) * 2004-10-13 2006-04-13 The Regents Of The University Of Michigan Anticancer compounds and methods
WO2006083906A2 (en) * 2005-02-01 2006-08-10 Attenuon, Llc Compositions containing the anti-angiogenic phscn-peptide
AU2006210627B2 (en) * 2005-02-01 2011-05-19 Attenuon, Llc Acid addition salts of Ac-PHSCN-NH2
EP2091914A4 (en) 2006-11-08 2010-12-29 Chongxi Yu TRANSDERMAL ADMINISTRATION SYSTEMS FOR PEPTIDES AND RELATED CONNECTIONS
AU2016213759B2 (en) * 2006-11-08 2018-03-29 Chongxi Yu Transdermal delivery systems of peptides and related compounds
PL2427475T3 (pl) 2009-05-08 2021-07-19 Techfields Biochem Co., Ltd. Kompozycje proleku o wysokim przenikaniu peptydów i związków powiązanych z peptydami
KR101228668B1 (ko) 2010-09-17 2013-01-31 가톨릭대학교 산학협력단 혈관신생 억제 활성을 갖는 펩타이드 및 이의 용도
CA2839702C (en) 2011-06-23 2021-04-20 Board Of Regents, The University Of Texas System Identifying peptides at the single molecule level
US11435358B2 (en) 2011-06-23 2022-09-06 Board Of Regents, The University Of Texas System Single molecule peptide sequencing
CN102417540A (zh) * 2011-11-21 2012-04-18 中国药科大学 一种聚乙二醇修饰的整合素阻断剂hm-3及其应用
WO2013170195A1 (en) * 2012-05-11 2013-11-14 Medicus Biosciences, Llc Biocompatible hydrogel treatments for retinal detachment
ES2664411T3 (es) 2013-03-15 2018-04-19 Suncor Energy Inc. Composiciones herbicidas
JP5970439B2 (ja) * 2013-09-20 2016-08-17 チョンシー ユー ペプチド及び関連化合物の経皮送達システム
EP3543703A1 (en) * 2014-09-15 2019-09-25 Board of Regents, The University of Texas System Improved single molecule peptide sequencing

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4440788A (en) * 1980-05-13 1984-04-03 Mitsubishi Chemical Industries, Limited Cysteine derivatives
WO1981003330A1 (en) 1980-05-13 1981-11-26 Mitsubishi Chem Ind Cysteine derivative and production thereof
US4394519A (en) * 1982-01-19 1983-07-19 Research Corporation Amino acid blocking agents
GB8504253D0 (en) * 1985-02-19 1985-03-20 Ici Plc Electrostatic spraying apparatus
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
DE3815221C2 (de) * 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
US5091176A (en) * 1988-11-02 1992-02-25 W. R. Grace & Co.-Conn. Polymer-modified peptide drugs having enhanced biological and pharmacological activities
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5229366A (en) * 1990-10-23 1993-07-20 Fuji Photo Film Co., Ltd. Peptide-containing polyethylene glycol derivatives and application thereof
US5149801A (en) * 1990-11-21 1992-09-22 The Regents Of The University Of California Boronated porphyrin compounds
US5561220A (en) * 1991-02-08 1996-10-01 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
US5608110A (en) * 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
US5639725A (en) * 1994-04-26 1997-06-17 Children's Hospital Medical Center Corp. Angiostatin protein
WO1996028205A1 (en) * 1995-03-14 1996-09-19 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosing unit
JP3585127B2 (ja) * 1995-03-14 2004-11-04 シーメンス アクチエンゲゼルシヤフト 超音波噴霧システム
US5618513A (en) * 1995-06-07 1997-04-08 Mallinckrodt Medical, Inc. Method for preparing radiolabeled peptides
MY147327A (en) * 1995-06-29 2012-11-30 Novartis Ag Somatostatin peptides
EP0927045B1 (en) * 1996-09-10 2005-12-14 The Burnham Institute Tumor homing molecules, conjugates derived therefrom, and methods of using same
US6331409B1 (en) * 1996-11-21 2001-12-18 The Regents Of The University Of Michigan Methods and compositions for wound healing
US6001965A (en) * 1996-11-21 1999-12-14 The Regents Of The University Of Michigan Anticancer compounds and methods
US6025150A (en) * 1996-11-21 2000-02-15 The Regents Of The University Of Michigan Methods and compositions for wound healing
WO1998030538A1 (fr) * 1997-01-14 1998-07-16 Kaneka Corporation Procede servant a preparer des derives de cysteine
US5994309A (en) * 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
AU9477398A (en) * 1997-09-10 1999-03-29 Burnham Institute, The Methods of identifying molecules that home to angiogenic vasculature in tumors
US5954047A (en) * 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
JP2002525265A (ja) * 1998-08-14 2002-08-13 アドミニストレイターズ オブ ザ トゥレーン エジュケーショナル ファウンド 成長ホルモン放出活性を有する化合物
WO2002057786A2 (en) 2001-01-18 2002-07-25 The Regents Of The University Of Michigan Compositions and methods for the use of fibronectin fragments in the diagnosis of cancer
EA200500871A1 (ru) * 2002-11-25 2006-04-28 Атеньюон, Ллк Пептиды, ингибирующие ангиогенез, миграцию клеток, инвазию клеток и пролиферацию клеток, композиции и их применение

Similar Documents

Publication Publication Date Title
JP2006514116A5 (ja)
JP2005500357A5 (ja)
HK1214253A1 (zh) -噁二唑苯甲酸化合物及其在無義抑制和疾病治療中的用途
IL190150A0 (en) New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease
JP2006502236A5 (ja)
WO2004062604A3 (en) Treatment of cancer with 2-deoxyglucose
IL170120A (en) 4,2,1 - Triazines, their use in the preparation of HIV treatment or prophylaxis drugs, containing pharmaceutical preparations and methods for their preparation
WO2007062093A3 (en) Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
EP1848418A4 (en) USE OF NORDIHYDROGUAIARETIC ACID DERIVATIVES FOR THE TREATMENT OF DRUG RESISTANT VIRAL AND MICROBIAL CANCERS AND INFECTIONS
JP2009516719A5 (ja)
JP2003526626A5 (ja)
JP2005507892A5 (ja)
JP2008513426A5 (ja)
GB2368525B (en) Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease
JP2005511619A5 (ja)
JP2008513427A5 (ja)
HK1085373A1 (en) Compound and use in the manufacture of a medicament for the treatment of benign prostatic hyperplasia and associated symptoms
MXPA03006776A (es) Uso de inhibidores de interleucina-18 para el tratamiento y/o prevencion de enfermedad cardiaca.
JP2005507888A5 (ja)
SI1545710T1 (sl) Uporaba N-(3-metoksi-5-metilpirazin-2-il)-2-(4-(1,3,4-oksadiazol-2-il)fenil) piridin-3-sulfonamida v zdravljenju raka
WO2006124573A3 (en) Treatment of cancer with 2-deoxyglucose
PL371251A1 (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
JP2005505605A5 (ja)
JP2005523891A5 (ja)
JP2007513894A5 (ja) Ｃｈｐ−ゲムシタビン複合剤および抗腫瘍剤、特に抗転移剤としてのその使用